Four children with biotinidase deficiency were identified during the first year of a neonatal screening program for this disease in the Commonwealth of Virginia. Two unrelated probands were identified among the 81,243 newborn infants who were screened. In addition, two siblings of one of these infants were found to be affected. Both probands had mild neurologic symptoms at two and four months, respectively, and the two older children had more severe neurologic abnormalities, cutaneous findings, and developmental delay at two and three years of age. However, none of the affected children had acute metabolic decompensation. Previous studies have shown that the administration of biotin to affected children can be a lifesaving procedure that can reverse acute symptoms and prevent irreversible neurologic damage. Our findings demonstrate that subtle neurologic abnormalities may appear as early as at two months of age and that developmental abnormalities may occur even in the absence of episodes of overt metabolic decompensation. Since screening and treatment are both inexpensive and effective and the incidence of the disease is well within the range of that of other metabolic diseases for which screening is performed, biotinidase deficiency should be added to the group of metabolic diseases for which screening is done in the neonatal period.
This article has been cited by other articles:
Reidling, J. C., Said, H. M.
(2007). Regulation of the human biotin transporter hSMVT promoter by KLF-4 and AP-2: confirmation of promoter activity in vivo. Am. J. Physiol. Cell Physiol.
292: C1305-C1312
[Abstract][Full Text]
Reidling, J. C., Nabokina, S. M., Said, H. M.
(2007). Molecular mechanisms involved in the adaptive regulation of human intestinal biotin uptake: a study of the hSMVT system. Am. J. Physiol. Gastrointest. Liver Physiol.
292: G275-G281
[Abstract][Full Text]
Balamurugan, K., Vaziri, N. D., Said, H. M.
(2005). Biotin uptake by human proximal tubular epithelial cells: cellular and molecular aspects. Am. J. Physiol. Renal Physiol.
288: F823-F831
[Abstract][Full Text]
Balamurugan, K., Ortiz, A., Said, H. M.
(2003). Biotin uptake by human intestinal and liver epithelial cells: role of the SMVT system. Am. J. Physiol. Gastrointest. Liver Physiol.
285: G73-G77
[Abstract][Full Text]
Nabokina, S. M., Subramanian, V. S., Said, H. M.
(2003). Comparative analysis of ontogenic changes in renal and intestinal biotin transport in the rat. Am. J. Physiol. Renal Physiol.
284: F737-F742
[Abstract][Full Text]
Chatterjee, N. S., Rubin, S. A., Said, H. M.
(2001). Molecular characterization of the 5' regulatory region of rat sodium-dependent multivitamin transporter gene. Am. J. Physiol. Cell Physiol.
280: C548-C555
[Abstract][Full Text]
Chatterjee, N. S., Kumar, C. K., Ortiz, A., Rubin, S. A., Said, H. M.
(1999). Molecular mechanism of the intestinal biotin transport process. Am. J. Physiol. Cell Physiol.
277: C605-C613
[Abstract][Full Text]
Said, H. M., Ortiz, A., McCloud, E., Dyer, D., Moyer, M. P., Rubin, S.
(1998). Biotin uptake by human colonic epithelial NCM460 cells: a carrier-mediated process shared with pantothenic acid. Am. J. Physiol. Cell Physiol.
275: C1365-C1371
[Abstract][Full Text]
Sutherland, S. J., Olsen, R. D., Michels, V., Schmidt, M. A., O'Brien, J. F.
(1991). Screening for Biotinidase Deficiency in Children with Unexplained Neurologic or Developmental Abnormalities. CLIN PEDIATR
30: 81-84
[Abstract]